These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7519439)

  • 1. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
    Smith CM; Ballard SA; Wyllie MG; Masters JR
    J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of testosterone in the human prostate and seminal vesicles.
    Kjoseland O; Tveter KJ; Attramadal A; Hansson V; Haugen HN; Mathisen W
    Scand J Urol Nephrol; 1977; 11(1):1-6. PubMed ID: 557833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate.
    Ghanadian R; Puah CM
    J Endocrinol; 1981 Feb; 88(2):255-62. PubMed ID: 6162906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone metabolism of fibroblasts grown from prostatic carcinoma, benign prostatic hyperplasia and skin fibroblasts.
    Schweikert HU; Hein HJ; Romijn JC; Schröder FH
    J Urol; 1982 Feb; 127(2):361-7. PubMed ID: 6174738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
    Wright F; Poizat R; Bongini M; Bozzolan F; Doukani A; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1985 Feb; 60(2):294-8. PubMed ID: 2578133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
    Hudson RW; Wherrett D
    J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
    Negri-Cesi P; Colciago A; Poletti A; Motta M
    Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
    Bard DR; Lasnitzki I
    J Endocrinol; 1977 Jul; 74(1):1-9. PubMed ID: 68984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 11β-hydroxyandrostenedione pathway and C11-oxy C
    du Toit T; Swart AC
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105497. PubMed ID: 31626910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
    Zoppi S; Cocconi M; Natali A; Costantini A; Serio M; Martini L; Motta M
    J Clin Endocrinol Metab; 1986 Jul; 63(1):269-71. PubMed ID: 2423549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen metabolism in the human prostatic cancer cell line LNCaP.
    Negri-Cesi P; Motta M
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):89-96. PubMed ID: 7947355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the possible existence of two 5 alpha-reductases in the rat prostate.
    Martini L; Zoppi S; Motta M
    J Steroid Biochem; 1986 Jan; 24(1):177-82. PubMed ID: 3702403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dihydrotestosterone in benign prostatic hyperplasia.
    Carson C; Rittmaster R
    Urology; 2003 Apr; 61(4 Suppl 1):2-7. PubMed ID: 12657354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
    Perel E; Killinger DW
    J Steroid Biochem; 1983 Aug; 19(2):1135-9. PubMed ID: 6193342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.
    Kaefer M; Audia JE; Bruchovsky N; Goode RL; Hsiao KC; Leibovitch IY; Krushinski JH; Lee C; Steidle CP; Sutkowski DM; Neubauer BL
    J Steroid Biochem Mol Biol; 1996 May; 58(2):195-205. PubMed ID: 8809201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
    du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
    J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts.
    Délos S; Carsol JL; Ghazarossian E; Raynaud JP; Martin PM
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):375-83. PubMed ID: 8541234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
    BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.